Levothyroxine BE [Design Issues]

posted by drcampos  – Brazil, 2007-07-19 23:56 (6457 d 05:51 ago) – Posting: # 913
Views: 8,395

Dear All,

Could someone provide information (articles) about linear pharmacokinetics of strenghts of levothyroxine sodium (25, 50, 75, 88, 100, 112, 125, 137, 150, 200 and 300 ug).

I intend to develop a BE study with the highest strength and ask for biowaiver to the lowest strenghts, because a dose of 600ug (2x 300ug) should be given to detect T4 above baseline levels according FDA Guidance (Levothyroxine Sodium Tablets — In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing - 2000).

Regards,

Daniel Rossi de Campos
Brazil

--
Edit: moved to previous thread. [HS]

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,677 registered users;
16 visitors (0 registered, 16 guests [including 4 identified bots]).
Forum time: 04:47 CET (Europe/Vienna)

There are no routine statistical questions,
only questionable statistical routines.    David R. Cox

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5